Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
1996 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Sequential external counterpulsation increases cerebral and renal blood flow
1997
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Oral Anticoagulant Therapy
2012 Standout
Interpretation of Changes in Health-related Quality of Life
2003 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
1998
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature
1992
Coumarin-Induced Skin Necrosis
1993
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
CHRONIC MESENTERIC ISCHEMIA
1997
The coagulation cascade: initiation, maintenance, and regulation
1991 Standout
The Clinical Course of Pulmonary Embolism
1992 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
1989
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Saphenous Vein Versus PTFE for Above-Knee Femoropopliteal Bypass. A Review of the Literature
2004
AGA technical review on intestinal ischemia
2000 Standout
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
1997 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
A 14-year study of heparin-induced thrombocytopenia
1996 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Cardiac Myxomas
1995 Standout
On the mechanisms of biocompatibility
2008 Standout
Disseminated Intravascular Coagulation
1999 Standout
Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument
1995
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Anticoagulant-induced skin necrosis in a patient with hereditary deficiency of protein S
1999
Sentinel Lymph Node Mapping of the Pleural Space
2005 StandoutNobel
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
The regeneration of aortic endothelium
1958
Open mitral commissurotomy
1980
Diagnostic and surgical aspects of left atrial tumors
1967
STUDIES ON INFLAMMATION
1961 StandoutNobel
Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation
2017
Evolution of Liver Transplantation
1982
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
1980 StandoutNatureNobel
DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage
1991
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Warfarin Necrosis of the Skin and Subcutaneous Tissue of the Male External Genitalia
1983
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor
2001
Thrombotic Complications of Heparin Therapy Including Six Cases of Heparin-Induced Skin Necrosis
1979
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
1984 Standout
Warfarin and Heparin-Induced Skin Necrosis and the Purple Toe Syndrome: Infrequent Complications of Anticoagulant Treatment
1997
Left Ventricular Systolic Unloading and Augmentation of Intracoronary Pressure and Doppler Flow During Enhanced External Counterpulsation
2002
Secretory products of macrophages.
1987 Standout
Warfarin-induced skin necrosis
1986
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Binding of human factor VII and VIIa to monocytes.
1982
Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium
1977 StandoutNobel
Antithrombotic Therapy for Venous Thromboembolic Disease
1995
Works of Deterling Ra being referenced
Synchronous external circulatory assist.
1964
Warfarin induced necrosis of the skin.
1978
The economic impact of acute variceal bleeding: cost-effectiveness implications for medical and surgical therapy.
1980
A clinical and pathological study of interatrial myxomas.
1998
Chronic mesenteric ischemia masquerading as cancer.
1979
Above-knee polytetrafluoroethylene femoropopliteal bypass graft: Is it a reasonable alternative to the below-knee reversed autogenous vein graft?
1983
THE LASER TREATMENT OF EXPERIMENTAL MALIGNANT TUMOURS.
1964
External synchronous assisted circulation: experimental and clinical evaluation.
1968
Dacron tube and bifurcation arterial prostheses produced to specification; experimental and clinical use.
1957
Carcinoma of the lung.
1962